Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 451–500 of 75328
On June 22, 2026, Ryan Cotterman, age 44, was appointed as Vice President, Chief Accounting Officer and principal accounting officer of Ingevity Corporation (the “Company”).
Scott Morris, co-founder and President of the Company, will retire effective as of October 20, 2026
Nicola Baty, the Company’s Chief Operating Officer since September 2024, will assume the additional role of President of the Company on the Separation Date.
The Company also announced that Simon Kerry, the Managing Director of the Company’s U.K. and Ireland regional business, will serve as interim Managing Director of the Company’s EMEA&APAC business during Mr. Whitehead’s medical leave period.
On June 24, 2026, Molson Coors Beverage Company (the “Company”) announced that Philip Whitehead, the President and Chief Executive Officer of the Company’s EMEA&APAC business, will be temporarily stepping away from his role due to a medical condition.
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.
Christopher Stokes and Kristina Mignon Wright were appointed as directors of the Company.
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.
Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
Mario Alberto Accardi, Ph.D. (Chief Executive Officer and Director), John Crowley, Stephen Kanes, M.D., Ph.D., and Raphael Deferiere ceased to serve in their capacities as executive officers of Centessa.
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
Christopher Stokes and Kristina Mignon Wright were appointed as directors of the Company.
each of Francesco De Rubertis, Mario Alberto Accardi, Arjun Goyal, Mary Lynne Hedley, Mathias Hukkelhoven, Samarth Kulkarni, Carol Stuckley and Brett Zbar ceased serving as a member of the board of directors of Centessa
the Board appointed Andreas Lieber as a member of the Board, effective immediately, to serve as a Class I director filling the vacancy created by the resignation of Mr. Maredia.
On June 17, 2026, Sarfraz Maredia, a member of the Board of Directors (the “Board”) of Serve Robotics Inc. (the “Company”) informed the Company of his decision to resign from the Board, effective immediately.
The Board appointed Richard Fang, Ph.D., 60, as the Company's Interim Chief Executive Officer, effective as of the Separation Date.
On June 17, 2026, Patrick NJ Schnegelsberg notified Picard Medical, Inc. (the "Company") of his decision to step down as Chief Executive Officer and as a member of the Board of Directors of the Company (the "Board"), effective June 18, 2026
the Board appointed Robert Azelby as a director of the Company to fill the newly created vacancy on the Board resulting from the increase to the board size.
appointed Haley R. Fisackerly as an independent Class II director
On June 16, 2026, the board of directors of the Company (the “Board”) promoted Cory Anderson from the position of Senior Vice President, Chief Technology Officer to the position of Executive Vice President, General Manager of Greenbrook effective July 1, 2026.
On June 22, 2026, Emanuel “Manny” Chirico informed Conagra Brands, Inc. (the “Company”) that he has decided not to stand for reelection to the Board of Directors at the Company’s 2026 Annual Meeting of Shareholders to be held in September.
On June 16, 2026, Ben M. Palmer, Director, President, and Chief Executive Officer of RPC, Inc. (the “Company”), notified the Company of his decision to retire as Director, President, and Chief Executive Officer, effective on the earlier of a successor being named or December 31, 2026, after which he will remain in an advisory capacity to support the transition of leadership.
On June 23, 2026, the Company announced the appointment of David Denton as Executive Vice President and Chief Financial Officer (“CFO”), effective as of August 16, 2026
On June 23, 2026, the Company also announced that, as of the Effective Date, Matthew Friend will cease serving as Executive Vice President and CFO and begin serving as an advisor to the Chief Executive Officer of the Company and remain a full-time non-executive employee of the Company in that role through his separation from the Company on September 4, 2026
On June 22, 2026, at the organizational meeting of the Board of Directors following the 2026 Annual Meeting of Shareholders, Burke & Herbert Financial Services Corp. (the “Company”) appointed Roy E. Halyama, the Company’s current Executive Vice President and Chief Financial Officer, as the President of the Company and the President of Burke & Herbert Bank & Trust Company (the “Bank”) effective July 1, 2026.
the previously announced retirement of H. Charles Maddy, III as the President of the Company and the Bank, effective June 30, 2026.
the Board of Directors of the Company has appointed Clinton Roeder as Executive Vice President and Chief Financial Officer of the Company, effective as of June 22, 2026.
Team, Inc. (the “Company”) announced that Nelson Haight will depart from his role as Executive Vice President and Chief Financial Officer of the Company, effective as of June 22, 2026.
On June 17, 2026, upon recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Moncef Slaoui to the Board as a Class II director, which appointment became effective immediately.
On June 17, 2026, Jacks Lee notified the Board of Directors (the “Board”) of Vaxcyte, Inc. (“the “Company”) of his retirement from the Board, effective as of June 17, 2026.
Mr. Young will succeed Joseph M. Busky, who previously announced his plans to retire
The Board of Directors of QuidelOrtho Corporation (the “Company”) has appointed Micah Young to serve as the Company’s Chief Financial Officer and principal financial officer, effective as of July 6, 2026
Effective January 1, 2027, John T. Robson, currently Assistant Vice President – Energy Engineering and Production of the Company, will be appointed Vice President – Energy Operations, succeeding Mr. Lorenz in that role.
James J. Lorenz, Vice President – Energy Operations of Madison Gas and Electric Company (the “Company”), notified the Company of his intention to retire effective December 31, 2026.
stepping down as the Company’s Chief Executive Officer and Chairman of the Board, effective June 17, 2026
Mr. Li Shanglong was appointed as Chairman of the Board
the Board appointed Mr. Li Shanglong to serve as director of the Company, effective as of the Effective Date
the Board appointed Mr. Weizhi (Eric) Shao to serve as Chief Executive Officer of the Company, effective as of the Effective Date
stepping down as the Company’s Chief Executive Officer and Chairman of the Board, effective June 17, 2026
Mr. Len Mertz who, as previously announced, did not stand for re-election as a director of the Company at the Meeting.
appointed Dr. Robert Wills as non-executive Chair of the Board.
On June 16, 2026, Bank First Corporation (the “Company”) elected three new directors to its Board of Directors, including SriRaj Kantamneni, Tracy C. Pearson and William J. Ring, each for a three-year term.
On June 16, 2026, Bank First Corporation (the “Company”) elected three new directors to its Board of Directors, including SriRaj Kantamneni, Tracy C. Pearson and William J. Ring, each for a three-year term.
On June 16, 2026, Bank First Corporation (the “Company”) elected three new directors to its Board of Directors, including SriRaj Kantamneni, Tracy C. Pearson and William J. Ring, each for a three-year term.
On June 16, 2026, the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) increased the size of the Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., to serve on the Board, effective immediately.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.